Dr Maria Teresa Esposito is a John Goldman fellow and is currently funded by Leuka and the British Society of Hematology.
1. Esposito, M. T. The impact of PI3-Kinase/RAS pathway cooperating mutations in the evolution of KMT2A- rearranged leukemia. Hemasphere in press (2019).
2. Esposito MT, Zhao L, Fung TK, Rane JK, Wilson A, Martine N, Gil J, Ashworth A, So CW. “Synthetic lethal targeting of oncogenic transcription factors in acute leukaemia using PARP inhibitors” Nature Medicine 2015 Dec 21 (12): 1481-90
3. Esposito MT and Chi Wai Eric So “DNA damage accumulation and repair defects in the pathogenesis of Acute Myeloid Leukaemia: implications for pathogenesis, disease progression and chemotherapy resistance.” Chromosoma 2014 Dec 123(6):545-61
FTE Category A staff submitted: 10.00
Research output data provided by the Research Excellence Framework (REF)Click here to see the results for all UK universities